Fig. 1From: Real-world evidence on siponimod treatment in patients with secondary progressive multiple sclerosisStudy design. Part A demonstrates the patients contributed by participating centres. Part B illustrates the timeline of clinical and radiological assessment. Part C depicts the two cohorts included in the study, with the additional parameters only being used in the in-depth cohortBack to article page